Akili Interactive, the Boston-based startup that got the first prescription video game approved last June, has raised another $160 million in funding for its work on digital therapeutics. Akili plans to use the money partly to expand its marketing of EndeavorRx, a video game approved by the Food and Drug Administration for children with ADHD. The financing round brings the 10-year-old company’s total venture funding to $230 million.